CTNNB1 and bone metastasis: Our result demonstrated that patients with bone metastasis in NSCLC carrying the AA/AC genotype of CTNNB1: rs1880481 had a significantly lower level of SCC-Ag than patients with the CC genotype (p = 0.002, Figure 4D).